Revolution Research Development from 2010 to 2024

RVMDW Stock   0.32  0.08  20.00%   
Revolution Medicines, Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 243.4 M in 2024. During the period from 2010 to 2024, Revolution Medicines, Research Development regression line of quarterly data had mean square error of 4348.8 T and geometric mean of  141,374,939. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
423.1 M
Current Value
243.4 M
Quarterly Volatility
88.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Research Development Growth Pattern

Below is the plot of the Research Development of Revolution Medicines, Warrant over the last few years. It is Revolution Medicines,'s Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Revolution Research Development Regression Statistics

Arithmetic Mean156,470,712
Geometric Mean141,374,939
Coefficient Of Variation56.74
Mean Deviation64,087,444
Median110,827,000
Standard Deviation88,780,494
Sample Variance7882T
Range312.3M
R-Value0.70
Mean Square Error4348.8T
R-Squared0.49
Significance0
Slope13,863,278
Total Sum of Squares110347.7T

Revolution Research Development History

2024243.4 M
2023423.1 M
2022253.1 M
2021186.9 M
2020132.3 M

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development423.1 M243.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.